Royal Bahrain Hospital Competitors and Similar CompaniesClear all

Royal Bahrain Hospital's competitors and similar companies include Kohinoor Hospital, Concord Medical, Eisai and Galicia Cancer Center.

	Royal Bahrain Hospital Royal Bahrain Hospital is a healthcare services provider.	Kohinoor Hospital Kohinoor Hospital is a provider of healthcare services.	Concord Medical Concord Medical (CCM, 泰和诚医疗集团) is a company that operates a network of cancer hospitals, as well as radiotherapy and diagnostic imaging centers.	Eisai Eisai (エーザイ株式会社) is a research-based human healthcare company that discovers, develops, packages, and markets pharmaceutical products.	Galicia Cancer Center Galicia Cancer Center is a hospital for cancer treatments.
Founding Date	Founding Date 2011	Founding Date 2009	Founding Date 1997	Founding Date 1941	Founding Date 1972
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare hospitals oncology pharma	Tags Healthcare hospitals oncology pharma surgical solutions	Tags Healthcare hospitals oncology	Tags Healthcare drug development hospitals oncology pharma	Tags Healthcare hospitals oncology
Locations	Locations Manama, BH HQ Manama, BH	Locations Mumbai, IN HQ	Locations Beijing, CN HQ	Locations Tokyo, JP HQ Melbourne, AU Wien, AT Leuven, BE Mississauga, CA see more	Locations A Coruña, ES HQ
Employees	Employees 324	Employees 210	Employees 6916% decrease	Employees 11,067	Employees 102
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 32.3 m	Valuation ($) 9.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥460.5m (FY, 2025)	Revenue (est.) ¥789.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥295.1m (FY, 2025)	Cost of goods ¥128.9b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥165.4m (FY, 2025)	Gross profit ¥677.7b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income (¥379.4m) (FY, 2025)	Net income ¥48.1b (FY, 2025)	Net income N/A